165 related articles for article (PubMed ID: 19393638)
1. Point-of-care fluorescence immunoassay for prostate specific antigen.
Oh SW; Kim YM; Kim HJ; Kim SJ; Cho JS; Choi EY
Clin Chim Acta; 2009 Aug; 406(1-2):18-22. PubMed ID: 19393638
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of fluorescence hs-CRP immunoassay for point-of-care testing.
Oh SW; Moon JD; Park SY; Jang HJ; Kim JH; Nahm KB; Choi EY
Clin Chim Acta; 2005 Jun; 356(1-2):172-7. PubMed ID: 15936314
[TBL] [Abstract][Full Text] [Related]
3. One-step immunostrip test for the simultaneous detection of free and total prostate specific antigen in serum.
Fernández-Sánchez C; McNeil CJ; Rawson K; Nilsson O; Leung HY; Gnanapragasam V
J Immunol Methods; 2005 Dec; 307(1-2):1-12. PubMed ID: 16277989
[TBL] [Abstract][Full Text] [Related]
4. Development of a point-of-care assay system for high-sensitivity C-reactive protein in whole blood.
Ahn JS; Choi S; Jang SH; Chang HJ; Kim JH; Nahm KB; Oh SW; Choi EY
Clin Chim Acta; 2003 Jun; 332(1-2):51-9. PubMed ID: 12763280
[TBL] [Abstract][Full Text] [Related]
5. A rapid, simple measurement of human albumin in whole blood using a fluorescence immunoassay (I).
Choi S; Choi EY; Kim DJ; Kim JH; Kim TS; Oh SW
Clin Chim Acta; 2004 Jan; 339(1-2):147-56. PubMed ID: 14687905
[TBL] [Abstract][Full Text] [Related]
6. Comparability of serum prostate-specific antigen measurement between the Roche Diagnostics Elecsys 2010 and the Abbott Architect i2000.
Gray MA; Cooke RR; Weinstein P; Nacey JN
Ann Clin Biochem; 2004 May; 41(Pt 3):207-12. PubMed ID: 15117434
[TBL] [Abstract][Full Text] [Related]
7. Point-of-care PSA testing: an evaluation of PSAwatch.
Karim O; Rao A; Emberton M; Cochrane D; Partridge M; Edwards P; Walker I; Davidson I
Prostate Cancer Prostatic Dis; 2007; 10(3):270-3. PubMed ID: 17353914
[TBL] [Abstract][Full Text] [Related]
8. A nanoparticle label/immunochromatographic electrochemical biosensor for rapid and sensitive detection of prostate-specific antigen.
Lin YY; Wang J; Liu G; Wu H; Wai CM; Lin Y
Biosens Bioelectron; 2008 Jun; 23(11):1659-65. PubMed ID: 18406127
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the automated AxSYM and ADVIA centaur immunoassays for homocysteine determination.
Haltmayer M; Mueller T; Gegenhuber A; Poelz W
Clin Lab; 2004; 50(3-4):175-80. PubMed ID: 15074472
[TBL] [Abstract][Full Text] [Related]
10. Homogeneous dual-parameter assay for prostate-specific antigen based on fluorescence resonance energy transfer.
Kokko T; Liljenbäck T; Peltola MT; Kokko L; Soukka T
Anal Chem; 2008 Dec; 80(24):9763-8. PubMed ID: 19012418
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence immunoassay of human D-dimer in whole blood.
Kim TK; Oh SW; Mok YJ; Choi EY
J Clin Lab Anal; 2014 Jul; 28(4):294-300. PubMed ID: 24578175
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of a prostate-specific antigen in serum using fluorescence immunochromatography.
Yoo J; Jung YM; Hahn JH; Pyo D
J Immunoassay Immunochem; 2010; 31(4):259-65. PubMed ID: 21113839
[TBL] [Abstract][Full Text] [Related]
13. Resin-based micropipette tip for immunochromatographic assays in urine samples.
Yuhi T; Nagatani N; Endo T; Kerman K; Takata M; Konaka H; Namiki M; Takamura Y; Tamiya E
J Immunol Methods; 2006 May; 312(1-2):54-60. PubMed ID: 16624320
[TBL] [Abstract][Full Text] [Related]
14. Complexed prostate specific antigen: better test in the diagnosis of prostate cancer for the clinically relevant 2.5-4 ng/ml total PSA range.
Mutlu N; Türkeri LN; Yencilek F; Demir A; Emerk K
Can J Urol; 2009 Apr; 16(2):4558-67. PubMed ID: 19364428
[TBL] [Abstract][Full Text] [Related]
15. Method comparison studies for prostate specific antigen and unconjugated estriol immunoassays.
Koenn ME; Ndah BV
Clin Lab Sci; 2003; 16(2):94-8. PubMed ID: 12757188
[TBL] [Abstract][Full Text] [Related]
16. Point-of-care fluorescence immunoassay for cardiac panel biomarkers.
Kim TK; Oh SW; Hong SC; Mok YJ; Choi EY
J Clin Lab Anal; 2014 Nov; 28(6):419-27. PubMed ID: 24652617
[TBL] [Abstract][Full Text] [Related]
17. [Development of a rapid method for the detection of prostate-specific antigen by immunochromatography].
Liubavina IA; Zinchenko AA; Lebedin IuS; Chukanov SV
Bioorg Khim; 2007; 33(5):550-4. PubMed ID: 18050661
[TBL] [Abstract][Full Text] [Related]
18. [Development of a method for the immunological measurement of aspartate aminotransferase with monoclonal antibodies].
Choi S; Kim DJ; Choi EY
Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):135-44. PubMed ID: 12824753
[TBL] [Abstract][Full Text] [Related]
19. Advent of innovative chemiluminescent enzyme immunoassay.
Lee JH; Rho JE; Rho TH; Newby JG
Biosens Bioelectron; 2010 Oct; 26(2):377-82. PubMed ID: 20739174
[TBL] [Abstract][Full Text] [Related]
20. New onset of heterophilic antibody interference in prostate-specific antigen measurement occurring during the period of post-prostatectomy prostate-specific antigen monitoring.
Fritz BE; Hauke RJ; Stickle DF
Ann Clin Biochem; 2009 May; 46(Pt 3):253-6. PubMed ID: 19264827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]